Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
;
Isabel
Dos-Santos-Silva
;
Lorna
Gibson
;
Heli
Nevanlinna
;
Taru A
Muranen
;
Kristiina
Aittomäki
;
Carl
Blomqvist
;
Per
Hall
;
Jingmei
Li
;
Jianjun
Liu
;
Keith
Humphreys
;
Daehee
Kang
;
Ji-Yeob
Choi
;
Sue K
Park
;
Dong-Young
Noh
;
Keitaro
Matsuo
;
Hidemi
Ito
;
Hiroji
Iwata
;
Yasushi
Yatabe
;
Pascal
Guénel
;
Thérèse
Truong
;
Florence
Menegaux
;
Marie
Sanchez
;
Barbara
Burwinkel
;
Frederik
Marme
;
Andreas
Schneeweiss
;
Christof
Sohn
;
Anna H
Wu
;
Chiu-Chen
Tseng
;
David
Van Den Berg
;
Daniel O
Stram
;
Javier
Benitez
;
M Pilar
Zamora
;
Jose Ignacio Arias
Perez
;
Primitiva
Menéndez
;
Xiao-Ou
Shu
;
Wei
Lu
;
Yu-Tang
Gao
;
Qiuyin
Cai
;
Angela
Cox
;
Simon S
Cross
;
Malcolm WR
Reed
;
Irene L
Andrulis
;
Julia A
Knight
;
Gord
Glendon
;
Sandrine
Tchatchou
;
Elinor J
Sawyer
;
Ian
Tomlinson
;
Michael J
Kerin
;
Nicola
Miller
;
Christopher A
Haiman
;
Brian E
Henderson
;
Fredrick
Schumacher
;
Loic
Le Marchand
;
Annika
Lindblom
;
Sara
Margolin
;
Soo Hwang
Teo
;
Cheng Har
Yip
;
Daphne SC
Lee
;
Tien Y
Wong
;
Maartje J
Hooning
;
John WM
Martens
;
J Margriet
Collée
;
Carolien HM
van Deurzen
;
John L
Hopper
;
Melissa C
Southey
;
Helen
Tsimiklis
;
Miroslav K
Kapuscinski
;
Chen-Yang
Shen
;
Pei-Ei
Wu
;
Jyh-Cherng
Yu
;
Shou-Tung
Chen
;
Grethe Grenaker
Alnæs
;
Anne-Lise
Borresen-Dale
;
Graham G
Giles
;
Roger L
Milne
;
Catriona
McLean
;
Kenneth
Muir
;
Artitaya
Lophatananon
;
Sarah
Stewart-Brown
;
Pornthep
Siriwanarangsan
;
Mikael
Hartman
;
Hui
Miao
;
Shaik Ahmad Bin Syed
Buhari
;
Yik Ying
Teo
;
Peter A
Fasching
;
Lothar
Haeberle
;
Arif B
Ekici
;
Matthias W
Beckmann
;
Hermann
Brenner
;
Aida Karina
Dieffenbach
;
Volker
Arndt
;
Christa
Stegmaier
;
Anthony
Swerdlow
;
Alan
Ashworth
;
Nick
Orr
;
Minouk J
Schoemaker
;
Montserrat
García-Closas
;
Jonine
Figueroa
;
Stephen J
Chanock
;
Jolanta
Lissowska
;
Jacques
Simard
;
Mark S
Goldberg
;
France
Labrèche
;
Martine
Dumont
;
Robert
Winqvist
;
Katri
Pylkäs
;
Arja
Jukkola-Vuorinen
;
Hiltrud
Brauch
;
Thomas
Brüning
;
Yon-Dschun
Koto
;
Paolo
Radice
;
Paolo
Peterlongo
;
Bernardo
Bonanni
;
Sara
Volorio
;
Thilo
Dörk
;
Natalia V
Bogdanova
;
Sonja
Helbig
;
Arto
Mannermaa
;
Vesa
Kataja
;
Veli-Matti
Kosma
;
Jaana M
Hartikainen
;
Peter
Devilee
;
Robert AEM
Tollenaar
;
Caroline
Seynaeve
;
Christi J
Van Asperen
;
Anna
Jakubowska
;
Jan
Lubinski
;
Katarzyna
Jaworska-Bieniek
;
Katarzyna
Durda
;
Susan
Slager
;
Amanda E
Toland
;
Christine B
Ambrosone
;
Drakoulis
Yannoukakos
;
Suleeporn
Sangrajrang
;
Valerie
Gaborieau
;
Paul
Brennan
;
James
McKay
;
Ute
Hamann
;
Diana
Torres
;
Wei
Zheng
;
Jirong
Long
;
Hoda
Anton-Culver
;
Susan L
Neuhausen
;
Craig
Luccarini
;
Caroline
Baynes
;
Shahana
Ahmed
;
Mel
Maranian
;
Catherine S
Healey
;
Anna
González-Neira
;
Guillermo
Pita
;
M Rosario
Alonso
;
Nuria
Alvarez
;
Daniel
Herrero
;
Daniel C
Tessier
;
Daniel
Vincent
;
Francois
Bacot
;
Ines
de Santiago
;
Jason
Carroll
;
Carlos
Caldas
;
Melissa A
Brown
;
Mathieu
Lupien
;
Vessela N
Kristensen
;
Paul DP
Pharoah
;
Georgia
Chenevix-Trench
;
Juliet D
French
;
Douglas F
Easton
;
Alison M
Dunning
;
Australian Ovarian Cancer Management Group
;
Australian Ovarian Cancer Management Group
;
(2014)
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Nature communications, 4 (1).
4999-.
ISSN 2041-1723
DOI: 10.1038/ncomms5999
GWAS have identified a breast cancer susceptibility locus on 2q35. Here we report the fine mapping of this locus using data from 101,943 subjects from 50 case-control studies. We genotype 276 SNPs using the 'iCOGS' genotyping array and impute genotypes for a further 1,284 using 1000 Genomes Project data. All but two, strongly correlated SNPs (rs4442975 G/T and rs6721996 G/A) are excluded as candidate causal variants at odds against >100:1. The best functional candidate, rs4442975, is associated with oestrogen receptor positive (ER+) disease with an odds ratio (OR) in Europeans of 0.85 (95% confidence interval=0.84-0.87; P=1.7 × 10(-43)) per t-allele. This SNP flanks a transcriptional enhancer that physically interacts with the promoter of IGFBP5 (encoding insulin-like growth factor-binding protein 5) and displays allele-specific gene expression, FOXA1 binding and chromatin looping. Evidence suggests that the g-allele confers increased breast cancer susceptibility through relative downregulation of IGFBP5, a gene with known roles in breast cell biology.
-
picture_as_pdf - ncomms5999.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0